PubRank

R Osborne

Author PubWeight™ 62.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 1987 3.66
2 The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999 3.29
3 Functional human corneal equivalents constructed from cell lines. Science 1999 2.74
4 Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer 2009 2.13
5 Analgesic activity of morphine-6-glucuronide. Lancet 1988 1.94
6 The variability of blood pressure measurements in children. Am J Public Health 1983 1.38
7 Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. Virology 2001 1.28
8 Isolation of bluetongue and related viruses from Culicoides spp. in the Sudan. J Hyg (Lond) 1984 1.23
9 Response to "randomized vertebroplasty trials: bad news or sham news?". AJNR Am J Neuroradiol 2009 1.18
10 Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol 2011 1.13
11 Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol 1995 1.11
12 Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. Ann Oncol 2011 1.09
13 Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 1999 1.08
14 Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol 1992 1.03
15 Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis. Toxicol Sci 2001 0.97
16 Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol In Vitro 2010 0.95
17 Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol 2000 0.95
18 Volumetric object modeling for surgical simulation. Med Image Anal 1998 0.95
19 Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol Appl Pharmacol 1985 0.93
20 A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1986 0.92
21 A collagen-based scaffold for a tissue engineered human cornea: physical and physiological properties. Int J Artif Organs 2003 0.92
22 Preliminary report of the lung cancer detection program in New York. Cancer 1977 0.91
23 The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies. Hematol Oncol 1988 0.90
24 Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor. Cancer Res 1982 0.90
25 Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine 1996 0.89
26 SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer. Br J Cancer 2006 0.89
27 Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol 1998 0.89
28 Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study. Gynecol Oncol 1995 0.87
29 Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. Br J Dermatol 2014 0.87
30 Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response. Vaccine 1996 0.87
31 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. Toxicol Appl Pharmacol 1985 0.86
32 Who attends primary care services prior to attendance at genitourinary services and what level of care have they received? Sex Transm Infect 2008 0.86
33 Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cell Dev Biol 1985 0.86
34 Tumor-promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells. Endocrinology 1981 0.85
35 Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 1990 0.85
36 A phase II study of leuprolide in advanced/recurrent endometrial cancer. Gynecol Oncol 1997 0.85
37 Risk assessment initiatives for noncancer endpoints: implications for risk characterization of chemical mixtures. Toxicol Ind Health 1989 0.84
38 Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol Sci 1999 0.84
39 High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 1994 0.84
40 Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3. Gynecol Oncol 1992 0.83
41 Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II study. Ann Oncol 2007 0.81
42 Brunner's gland adenoma of the duodenum. Am J Dig Dis 1973 0.81
43 Hydrocortisone increases the number of receptors for thyrotropin-releasing hormone on pituitary cells in culture. Biochem Biophys Res Commun 1977 0.80
44 Determination of the intra- and interlaboratory reproducibility of the low volume eye test and its statistical relationship to the Draize eye test. Regul Toxicol Pharmacol 1996 0.80
45 Development of an in vitro method for skin corrosion testing. Fundam Appl Toxicol 1996 0.80
46 CJD and intraocular surgery. Eye (Lond) 2004 0.79
47 'Getting your life back on track after stroke': a Phase II multi-centered, single-blind, randomized, controlled trial of the Stroke Self-Management Program vs. the Stanford Chronic Condition Self-Management Program or standard care in stroke survivors. Int J Stroke 2009 0.79
48 Assessment of chemical disinfectants against human immunodeficiency virus: overcoming the problem of cytotoxicity and the evaluation of selected actives. J Virol Methods 1993 0.79
49 Relationship of difficult forceps delivery to dental arches and occlusion. Pediatr Dent 1994 0.78
50 Changing concepts in the management of vulvar cancer. Gynecol Oncol 1991 0.77
51 Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment. Environ Health Perspect 1985 0.77
52 In vitro and human testing strategies for skin irritation. Ann N Y Acad Sci 2000 0.77
53 Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies. Vaccine 1992 0.77
54 Evaluation of metallothionein and p53 expression as potential prognostic markers for laryngeal squamous cell carcinoma. Cell Mol Biol (Noisy-le-grand) 2003 0.77
55 1-amino-3,7,8-trichlorodibenzo-p-dioxin: a specific antagonist for TCDD-induced myelotoxicity. Biochem Biophys Res Commun 1986 0.77
56 Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989 0.76
57 Strategies for the assessment of acute skin irritation potential. J Pharmacol Toxicol Methods 1999 0.76
58 The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. Br J Cancer 1991 0.75
59 Good manners for the pharmaceutical industry. Lancet 1997 0.75
60 Morphine intoxication in renal failure; the role of morphine-6-glucuronide. Br Med J (Clin Res Ed) 1986 0.75
61 Differences in the morbidity of radical hysterectomy between gynecological oncologists. Gynecol Oncol 1993 0.75
62 Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups. Br J Cancer 1997 0.75
63 Cross talk. Nurs Stand 1996 0.75
64 Near-infrared continuum generation with upconversion into the visible in SiO(2) single-mode fiber. Opt Lett 1994 0.75
65 High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancer. Cancer Chemother Pharmacol 1987 0.75
66 Review of a series of ureterovesicoplasties. J Urol 1968 0.75
67 Myotropic effects of new proctolin analogues modified in the position 5 of peptide chain in insects. Pol J Pharmacol 2002 0.75
68 Assessment of the Cytosensor Microphysiometer Assay in the COLIPA In Vitro Eye Irritation Validation Study. Toxicol In Vitro 1999 0.75
69 Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapy. Gynecol Oncol 1986 0.75
70 A report from Biopharm America 2013 - sixth Annual International Partnering Conference (September 16-19, 2013 - Boston, Massachusetts, USA). Drugs Today (Barc) 2013 0.75
71 Experiential learning: was it good for you? Nurs Stand 1991 0.75
72 Accept the new. Nurs Stand 1996 0.75
73 The Performance of the Tissue Equivalent Assay using the Skin(2)(TM) ZK1200 Model in the COLIPA International Validation Study on Alternatives to the Draize Eye Irritation Test. Toxicol In Vitro 1999 0.75
74 Think about it--would you like to be a client of the NHS now? Nurs Stand 1985 0.75
75 Qualifying statement. Nurs Stand 1987 0.75
76 Aorto-iliac reconstruction without arteriography. Am J Surg 1996 0.75
77 Student loans. A loan and broke in nursing. Nurs Stand 1989 0.75
78 Conformational and receptor-binding properties of the insect neuropeptide proctolin and its analogues. J Comput Aided Mol Des 1996 0.75
79 Tradimus. An end to the Project. Nurs Stand 1993 0.75
80 Consequences of selection techniques on selection for disease resistance and elimination of specific pathogens. Worlds Poult Sci J 1969 0.75
81 'Stay nursing, stay motivated'. Nurs Stand 1996 0.75
82 Speak your mind. Nurs Stand 1991 0.75
83 Tradimus. Whistleblowing: nursing? Whistle for it. Nurs Stand 1992 0.75
84 APHEDA, ACTU aid agency, takes union humanitarian ideals abroad. Qld Nurse 1991 0.75
85 Responding to rights. Nurs Stand 1990 0.75
86 Putting you in the picture. Nurs Stand 1999 0.75
87 Save essential homes. Nurs Stand 1985 0.75
88 Androgenetic complete mole with trisomy 13: report of a case with microsatellite genotyping and review of the literature. Pathol Res Pract 2010 0.75
89 The PRB has done nurses proud in 1985. Nurs Stand 1985 0.75
90 Further proctolin analogues modified in the position 2 of the peptide chain and their myotropic effects in insects Tenebrio molitor and Schistocerca gregaria. Pol J Pharmacol 1999 0.75
91 Synthesis and biological evaluation of selected insect neuropeptide analogs modified by D- or L-phenylglycine derivatives. Acta Pol Pharm 2000 0.75
92 Save essential homes. Nurs Stand 1985 0.75
93 Tradimus. Equal opportunities: defining equality. Nurs Stand 1992 0.75
94 All together and united. Nurs Stand 1991 0.75
95 Beyond the blot: cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes. Br J Dermatol 2012 0.75
96 IRAG working group 3. Cell function-based assays. Interagency Regulatory Alternatives Group. Food Chem Toxicol 1997 0.75
97 New proctolin analogues and their myotropic effects on heart of yellow mealworm Tenebrio molitor L. and foregut of locust-Schistocerca gregaria L. Pol J Pharmacol 1999 0.75
98 IRAG working group 5. Other assays. Interagency Regulatory Alternatives Group. Food Chem Toxicol 1997 0.75
99 Real poverty nightmare. Nurs Stand 1995 0.75
100 Review of autologous and allogeneic blood transfusion practices in patients undergoing radical hysterectomy. Eur J Gynaecol Oncol 1997 0.75
101 No limits. ANS: your questions answered.... Nurs Stand 1995 0.75
102 Tradimus. Student networks work. Nurs Stand 1992 0.75
103 Aromatherapy in practice: creative nursing care--Daw House Hospice. Aust J Holist Nurs 1998 0.75
104 A clearer picture of the views held by this year's student representative. Nurs Stand 1984 0.75
105 Education is catalyst for the profession. Nurs Stand 1986 0.75
106 Tradimus. Students at centre stage. Nurs Stand 1992 0.75
107 A hazard of double-orifice epidural catheters. Anesthesiology 1978 0.75
108 HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess. Eye (Lond) 2006 0.75
109 Surgical manifestations and results of treatment of pulmonary coccidioidomycosis. Ann Thorac Surg 1980 0.75